Premium
Biomea Fusion Inc (BMEA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical program’s drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical tria... Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical program’s drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of icovamenib for treating insulin-deficient type 2 diabetes; and COVALENT-212, which is in Phase II clinical trial of icovamenib for the treatment of type 2 diabetes. The company is also developing BMF-650, which is in Phase I glucagon-like peptide-131 clinical trial for the treatment of obesity. The company was incorporated in 2017 and is headquartered in San Carlos, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.11 | -7.80141843972 | 1.41 | 1.48 | 1.25 | 1052820 | 1.35881236 | CS |
| 4 | -0.32 | -19.7530864198 | 1.62 | 1.7 | 1.21 | 1112461 | 1.3876297 | CS |
| 12 | -0.11 | -7.80141843972 | 1.41 | 2.237 | 1.07 | 1559120 | 1.56465407 | CS |
| 26 | -0.07 | -5.10948905109 | 1.37 | 2.237 | 1.03 | 1373425 | 1.46159494 | CS |
| 52 | -1.59 | -55.0173010381 | 2.89 | 3.08 | 0.8719 | 1474478 | 1.64423572 | CS |
| 156 | -33.83 | -96.2994591517 | 35.13 | 43.69 | 0.8719 | 1190506 | 6.63975761 | CS |
| 260 | -17.78 | -93.1865828092 | 19.08 | 43.69 | 0.8719 | 807654 | 8.18682534 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
